GSK, Warp Drive form library alliance | Chemical & Engineering News
Volume 95 Issue 14 | p. 19 | Concentrates
Issue Date: April 3, 2017

GSK, Warp Drive form library alliance

Department: Business
Keywords: medicinal chemistry, small molecules, compound libraries

GlaxoSmithKline and Warp Drive Bio are joining small-molecule generation technologies to create a library of up to 200 million compounds. The alliance combines Warp Drive’s Small Molecule-Assisted Receptor Targeting platform with GSK’s Encoded Library Technology to create compounds targeting disease-causing proteins previously considered to be intractable. Each company will independently develop and commercialize drugs against its respective targets.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment